Mindfulness-Based Stress Reduction Safe, Effective for Anxiety Disorders
THURSDAY, Nov. 10, 2022 (HealthDay News) -- A standardized, evidence-based mindfulness intervention is noninferior to pharmacotherapy for the treatment of anxiety disorders, according to a study published online Nov. 9 in JAMA Psychiatry.
Elizabeth A. Hoge, M.D., from Georgetown University Medical Center in Washington, D.C., and colleagues assessed whether mindfulness-based stress reduction is noninferior to escitalopram, a commonly used first-line psychopharmacological treatment for anxiety disorders. The analysis included 208 U.S. adults diagnosed with anxiety disorder who were randomly assigned (1:1) to a weekly mindfulness-based stress reduction course or escitalopram (flexibly dosed from 10 to 20 mg).
The researchers found that mean Clinical Global Impression of Severity scale scores dropped by 1.35 for mindfulness versus 1.43 for escitalopram, indicating noninferiority. Noninferiority of mindfulness versus escitalopram was also seen in secondary intent-to-treat analyses using imputed data. Fewer patients who started treatment dropped out due to adverse events in the mindfulness group versus the escitalopram group (0 versus 10). Occurrence of at least one study-related adverse event was also lower for mindfulness versus escitalopram (15.4 versus 78.6 percent).
"It is important to note that although mindfulness meditation works, not everyone is willing to invest the time and effort to successfully complete all of the necessary sessions and do regular home practice which enhances the effect," Hoge said in a statement.
Two authors disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Related Posts
It’s Rare, But Kids Can Get an Alzheimer’s-Like Illness
WEDNESDAY, June 21, 2023 (HealthDay News) -- When people think about Alzheimer's...
Research Supporting Homeopathy Is Often Biased, of Poor Quality: Review
WEDNESDAY, March 16, 2022 (HealthDay News) -- Homeopathy's effectiveness may be...
Las chicas con diabetes tipo 2 tienen un riesgo más alto de quistes ováricos
MIÉRCOLES, 16 de febrero de 2022 (HealthDay News) -- La epidemia de obesidad...
How Common Is Opioid Misuse Among Seniors After Hip Surgery?
TUESDAY, Aug. 31, 2021 (HealthDay News) -- Many seniors who undergo surgery...